Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,129 public trials 394 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects

NCT01066962

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Allgemeines Krankenhaus der Stadt Wien Vienna, Austria
  • Otto Wagner Spital mit Pflegezentrum Vienna, Austria
  • ITZ Antwerpen Antwerp, Belgium
  • CHU Saint Pierre Brussels, Belgium
View all 77 locations
View Trial Details
Completed

Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options

NCT00144287

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Boehringer Ingelheim Investigational Site Aachen, Germany
  • Boehringer Ingelheim Investigational Site Berlin, Germany
  • Boehringer Ingelheim Investigational Site Berlin, Germany
  • Boehringer Ingelheim Investigational Site Berlin, Germany
View all 53 locations
View Trial Details
Completed

Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk Populations

NCT00710060

Conditions
Blood-Borne Infections, Communicable Diseases, Disease Attributes, +14 more
Locations
  • Fujian Institute of Health Education Fuzhou, China
  • YRG Centre for AIDS Research and Education (YRGCARE) Chennai, India
  • Universidad Peruana Cayetano Heredia Lima, Peru
  • Biomedical Center Saint Petersburg, Russia
View Trial Details
Completed

A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)

NCT00144183

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Boehringer Ingelheim Investigational Site Attridgeville, South Africa
  • Boehringer Ingelheim Investigational Site Cape Town, South Africa
  • Boehringer Ingelheim Investigational Site Durban, South Africa
  • Boehringer Ingelheim Investigational Site Johannesburg, South Africa
View Trial Details
Completed

Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients

NCT00274001

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Ospedale Regionale Ancona, Italy
  • Ospedale Santa Maria Annunziata Antella (fi), Italy
  • Clinica di Malattie Infettive Bari, Italy
  • Ospedali Riuniti di Bergamo Bergamo, Italy
View all 24 locations
View Trial Details
Completed

Trial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric Patients

NCT00273975

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Groote Schuur Hospital Cape Town, South Africa
  • Boehringer Ingelheim Investigational Site Pretoria, South Africa
  • Boehringer Ingelheim Investigational Site Soweto, South Africa
  • Boehringer Ingelheim Investigational Site Tygerberg, South Africa
View Trial Details

Related conditions